Literature DB >> 23220981

The different mechanisms of periprocedural myocardial infarction and their impact on in-hospital outcome.

Xavier Muschart1, Alisson Slimani, Jacques Jamart, Patrick Chenu, Vincent Dangoisse, Laurence Gabriel, Antoine Guédès, Baudouin Marchandise, Erwin Schröder.   

Abstract

BACKGROUND: CK-MB levels exceeding 3 times the upper limit of normal (ULN) following percutaneous coronary intervention (PCI), defining periprocedural myocardial infarction (PMI), are associated with worse outcomes. This study assessed the incidence and mechanisms of PMI and their impact on in-hospital stay. METHODS AND
RESULTS: Over a 12-year period (1996-2007), 272 cases of PMI (overall incidence, 3.5%) were analyzed among 310 consecutive cases of periprocedural myocardial necrosis (PMN; CK-MB > ULN). Mean numbers of treated segments and stents per procedure were 1.87 ± 0.99 and 1.43 ± 1.01, respectively. Mean stent length per procedure was 29.50 ± 19.30 mm. Following analysis of angiogram, procedural data, delay between PCI and necrosis, and mechanisms of PMN were classified as follows: cryptogenic (by exclusion, 41.5%), immediate failure, side-branch occlusion (14.0% each), stent thrombosis (10.6%), prolonged ischemia (9.2%), delayed failure (8.1%), post coronary artery bypass graft (1.5%), and non-target lesion related MI (1.1%). Significantly more stents were used in stent thrombosis, prolonged ischemia during PCI, and cryptogenic cases. In-hospital mortality was 8.1% for PMN and 8.8% for periprocedural MI, decreasing from non-target lesion related MI (25.0%) to mechanisms linked to stent thrombosis (20.7%), immediate failure (17.5%), delayed failure (7.7%), cryptogenic causes (6.1%), and prolonged ischemia (3.4%). Multivariate analysis confirms that in-hospital mortality is influenced by stent thrombosis, age, ejection fraction, and extent of coronary artery disease.
CONCLUSIONS: The precise mechanism of PMI was determined in about 60% of our series. Stent thrombosis and immediate failure had the poorest in-hospital outcomes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23220981

Source DB:  PubMed          Journal:  J Invasive Cardiol        ISSN: 1042-3931            Impact factor:   2.022


  6 in total

Review 1.  Factors Impacting Stent Thrombosis in Patients With Percutaneous Coronary Intervention and Coronary Stenting: A Systematic Review and Meta-Analysis.

Authors:  Nso Nso; Mahmoud Nassar; Milana Zirkiyeva; Yolanda Mbome; Anthony Lyonga Ngonge; Solomon O Badejoko; Shahzad Akbar; Atika Azhar; Sofia Lakhdar; Laura M Guzman Perez; Yousef Abdalazeem; Vincent Rizzo; Most Munira
Journal:  Cureus       Date:  2022-04-09

2.  Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI).

Authors:  Issam D Moussa; Lloyd W Klein; Binita Shah; Roxana Mehran; Michael J Mack; Emmanouil S Brilakis; John P Reilly; Gilbert Zoghbi; Elizabeth Holper; Gregg W Stone
Journal:  J Am Coll Cardiol       Date:  2013-10-22       Impact factor: 24.094

3.  Pre-procedural Serum Lipid Profile and Post-procedural Myocardial Injury.

Authors:  Hamidreza Sanati
Journal:  Res Cardiovasc Med       Date:  2013-10-28

4.  Incidence and impact on prognosis of peri-procedural myocardial infarction in 2760 elective patients with stable angina pectoris in a historical prospective follow-up study.

Authors:  Martin Kirk Christensen; Hui Huang; Christian Torp-Pedersen; Torleif Trydal; Jan Ravkilde
Journal:  BMC Cardiovasc Disord       Date:  2016-06-16       Impact factor: 2.298

5.  Impact of coronary artery calcification on percutaneous coronary intervention and postprocedural complications.

Authors:  Rami M Abazid; M Obadah Kattea; Osama A Smettei; Yasir Beshir; Haitham Sakr
Journal:  J Saudi Heart Assoc       Date:  2016-05-17

6.  Is Local Nitric Oxide Availability Responsible for Myocardial Salvage after Remote Preconditioning?

Authors:  Esbeidira Aranet Arroyo-Martínez; Alejandra Meaney; Gabriela Gutiérrez-Salmeán; Juan Miguel Rivera-Capello; Vidal González-Coronado; Alejandro Alcocer-Chauvet; Genaro Castillo; Nayelli Nájera; Guillermo Ceballos; Eduardo Meaney
Journal:  Arq Bras Cardiol       Date:  2016-07-11       Impact factor: 2.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.